Truist Biotech Analyst Karnauskas holds a conference call with CEO Salzmann on January 5 at 2 pm.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IMVT:
- Immunovant upgraded to Overweight from Equal Weight at Wells Fargo
- Roivant’s upcoming data readouts could move stock higher, says Cantor Fitzgerald
- Immunovant price target raised to $17 from $16 at H.C. Wainwright
- Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th